Glecaprevir/Pibrentasvir
성인

성인

Usual dose

3 tablets once daily (1 tablet = Glecaprevir 100 mg/Pibrentasvir 40 mg)

  • Take with food
Duration
  • Genotype 1-6, treatment-naïve, non-cirrhotic: 8 weeks
  • Genotype 1-6, treatment-naïve, compensated cirrhotic: 12 weeks (국내허가사항: 8주)
  • Genotype 1, previously treated with NS5A inhibitor, not previously treated with NS3/4a protease inhibitor, compensated cirrhotic/non-cirrhotic: 16 weeks
  • Genotype 1, previously treated with NS3/4a protease inhibitor, not previously treated with NS5A inhibitor, compensated cirrhotic/non-cirrhotic: 12 weeks
  • Genotype 1, 2, 4-6, previously treated with interferon, ribavirin, or sofosbuvir, no previous experience with NS5A or NS3/4A inhibitor, non-cirrhotic: 8 weeks
  • Genotype 1, 2, 4-6, previously treated with interferon, ribavirin, or sofosbuvir, no previous experience with NS5A or NS3/4A inhibitor, compensated cirrhotic: 12 weeks
  • Genotype 3, previously treated with interferon, ribavirin, or sofosbuvir, no previous experience with NS5A or NS3/4A inhibitor, compensated cirrhotic/non-cirrhotic: 16 weeks
No renal dose adjustment